MSNEXT
MSNEXT 是一项旨在表征在西班牙接受芬戈莫德的 RRMS 患者 (N=804) 的人口统计学和临床特征,并在临床实践中评估药物有效性和安全性的研究,且至少随访 12 个月
AE 和 SAE 的发生率1


It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.
This website is for non-promotional purposes and is intended for providing
safety information for healthcare professionals (HCP) only
Please confirm that you are an HCP
For HCPs: Information on this website is not country specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.
For non-HCPs / patients: This safety website is available for HCPs only